Uploaded October 2018 | Updated November 2026, 3 hours ago
Nine-year-old Creed Pettit was slowly going blind from a rare inherited genetic condition called Leber congenital amaurosis. Within days of receiving a revolutionary new gene therapy, he could see. This is the first and only FDA-approved gene therapy for an inherited genetic defect.
Get more information about eye health and read Creed's full story: aao.org/eye-health/patient-stories-detail/creed-gene-therapy
Nine-year-old Creed Pettit was slowly going blind from a rare inherited genetic condition called Leber congenital amaurosis. Within days of receiving a revolutionary new gene therapy, he could see. This is the first and only FDA-approved gene therapy for an inherited genetic defect.
Get more information about eye health and read Creed's full story: aao.org/eye-health/patient-stories-detail/creed-gene-therapy










